Veradermics (MANE) director boosts stake via IPO conversions and $17 share purchase
Rhea-AI Filing Summary
Veradermics, Inc. director Vladimir Coric reported multiple equity-acquiring transactions in connection with the company’s initial public offering. On February 5, 2026, Series A, B, and C convertible preferred shares automatically converted into common stock on a 10.067-for-1 basis immediately before the IPO closing.
These conversions resulted in common stock holdings shown at 33,706 shares from Series A, 148,794 from Series B, and additional common shares from Series C, split between direct ownership and entities referenced in the footnotes. Through the Vladimir Coric Family Trust 2013 and the Vladimir Coric Marital Trust 2013, indirect positions increased via these conversions.
On February 5, 2026, the trusts also executed an open-market purchase of 58,823 shares of common stock at $17 per share, bringing indicated indirect common stock holdings to 319,398 shares. Separately, on February 3, 2026, Coric received a stock option grant covering 51,525 shares at a $17 exercise price, which becomes fully vested and exercisable on February 3, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series A Convertible Preferred Stock | 33,706 | $0.00 | -- |
| Conversion | Series A Convertible Preferred Stock | 33,706 | $0.00 | -- |
| Conversion | Series B Convertible Preferred Stock | 148,794 | $0.00 | -- |
| Conversion | Series B Convertible Preferred Stock | 148,794 | $0.00 | -- |
| Conversion | Series C Convertible Preferred Stock | 78,075 | $0.00 | -- |
| Conversion | Series C Convertible Preferred Stock | 78,075 | $0.00 | -- |
| Conversion | Series C Convertible Preferred Stock | 117,112 | $0.00 | -- |
| Conversion | Common Stock | 33,706 | $0.00 | -- |
| Conversion | Common Stock | 33,706 | $0.00 | -- |
| Conversion | Common Stock | 148,794 | $0.00 | -- |
| Conversion | Common Stock | 148,794 | $0.00 | -- |
| Conversion | Common Stock | 78,075 | $0.00 | -- |
| Conversion | Common Stock | 78,075 | $0.00 | -- |
| Conversion | Common Stock | 117,112 | $0.00 | -- |
| Purchase | Common Stock | 58,823 | $17.00 | $1000K |
| Purchase | Common Stock | 58,823 | $17.00 | $1000K |
| Grant/Award | Stock Option (Right to Buy) | 51,525 | $0.00 | -- |
Footnotes (1)
- On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date. Shares held by Vladimir Coric Family Trust 2013. Shares held by Vladimir Coric Marital Trust 2013. On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date. On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date. This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.
